Medford, MA, United States of America

Matthew Milnes Dobbin

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Matthew Milnes Dobbin: Innovator in Membrane Fusion Technologies

Introduction

Matthew Milnes Dobbin is a notable inventor based in Medford, MA (US). He has made significant contributions to the field of biotechnology, particularly in the area of membrane fusion technologies. His innovative work has the potential to impact various applications in medicine and biology.

Latest Patents

Matthew Milnes Dobbin holds a patent for "Compositions for facilitating membrane fusion and uses thereof." This patent describes fusosome compositions and methods that comprise membrane-enclosed preparations containing a fusogen. In certain embodiments, the fusosome can target a cell, thereby delivering complex biologic agents directly to the target cell cytoplasm. This advancement could lead to new therapeutic strategies in treating various diseases.

Career Highlights

Matthew is currently associated with Flagship Pioneering Innovations V, Inc., where he continues to develop and refine his innovative ideas. His work at this company allows him to collaborate with other leading experts in the field, further enhancing the impact of his inventions.

Collaborations

Some of his notable coworkers include Geoffrey Von Maltzahn and John Miles Milwid. Their collaboration fosters a dynamic environment for innovation and research, contributing to the advancement of biotechnological solutions.

Conclusion

Matthew Milnes Dobbin is a distinguished inventor whose work in membrane fusion technologies holds promise for future medical applications. His contributions to the field exemplify the importance of innovation in addressing complex biological challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…